Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Importation Plan Builds On Use Of Authorized Generics To Lower US List Prices

Executive Summary

Plan envisions manufacturers, acting under FDA guidance, will import their own drugs and introduce them in the US under a new national drug code at a lower list price.

You may also be interested in...



US FDA Importation Proposal: Rigorous Requirements May Limit Impact

Proposed rule allowing states to import certain drugs from Canada would require tight supply chain, extensive security and reporting responsibilities. The potential costs and rigor involved in implementing the program could impede its uptake. 

US Drug Importation: Hard To See Path Forward, Former HHS Adviser Says

Former drug pricing advisor John O’Brien discusses next steps for Administration policies around importation and international reference pricing during a speech to the Academy of Managed Care Pharmacy.

Key Senator Hinges Support For Cheap Drug Imports On Surprise Inspections

More unannounced inspections abroad would warm Senate Finance Committee chairman to President Trump's drug importation plan.

Related Content

Topics

UsernamePublicRestriction

Register

PS140605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel